Novartis And Qualcomm Partner In mHealth
Executive Summary
The companies are partnering to invest in start-ups that have the potential to change health care delivery and are using Qualcomm’s 2net Platform in a clinical trial to aggregate patient data and personalize treatments.
You may also be interested in...
Novartis Execs Highlight Cosentyx, LCZ696 As Key 2015 Launches
The swapping of product portfolios with other companies remains on track at Switzerland’s big pharma Novartis, despite a seven-percentage-point sales erosion due to emerging generic competition during 2014, and more recent currency turmoil in its home country.
Digital Health Tools Ready For A Health Care System That Isn’t
Companies developing new digital health technologies say that the US health system needs to upgrade and start adopting tools that can track patients beyond hospital walls. Qualcomm Life aims to assist by merging data into information that health care providers can actually use.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”